OCT 13, 2015 04:51 PM PDT
Cytokine IL-17 Could Be New Drug Target for Psoriasis
POSTED BY: Kara Marker
3 11 1063

Psoriasis is a chronic autoimmune disorder causing inflammation of the skin. The exact cause is unknown, but scientists do know that a large volume of inflammatory cells are released as an immune response, inflaming skin and creating a vicious cycle of inflammation.

As knowledge surrounding T helper cell types increases, scientists have discovered more potential drug targets for treating psoriasis. Cytokine interleukin 17 and others in the IL-17 pathway are the newest drug targets for psoriasis therapies.

Loading Comments...